Ovid Therapeutics (OVID) Cash from Financing Activities (2016 - 2026)
Ovid Therapeutics (OVID) posted Cash from Financing Activities of $21.6 million for Q2 2026, down 75.7% from the prior quarter.
Ovid Therapeutics (OVID) Cash from Financing Activities (2016 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Cash from Financing Activities at Ovid Therapeutics was $185.78 million; for FY2025, it came in at $75.21 million.
- Annual Cash from Financing Activities shows a five-year compound annual growth rate of 9.8% (FY2020 to FY2025).
- In prior years, Ovid Therapeutics' Cash from Financing Activities was $622,000 in FY2024 (-98.0%), $30.54 million in FY2023, $180,658 in FY2022 (-80.0%) and $904,082 in FY2021 (-98.1%).
- Quarterly Cash from Financing Activities has run from a low of -$43,599 in Q4 2022 to a high of $88.98 million in Q1 2026 over five years.
- The strongest year-over-year quarter for Cash from Financing Activities in the past five years was Q1 2024, with growth of 240.3%; the weakest was Q3 2021, with a decline of 98.8%.
- According to Business Quant data, Cash from Financing Activities for the three prior quarters was $88.98 million (Q1 2026), $75.18 million (Q4 2025) and $15,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Ovid Therapeutics | 460.04 Mn | 92.06 Mn | - | 21.60 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.60 Mn |
| Mar 31, 2026 | 88.98 Mn |
| Dec 31, 2025 | 75.18 Mn |
| Sep 30, 2025 | 15,000.00 |
| Mar 31, 2025 | 13,000.00 |
| Sep 30, 2024 | 38,000.00 |
| Jun 30, 2024 | 356,000.00 |
| Mar 31, 2024 | 228,000.00 |
| Dec 31, 2023 | 30.03 Mn |
| Sep 30, 2023 | 224,000.00 |
| Jun 30, 2023 | 211,000.00 |
| Mar 31, 2023 | 67,000.00 |
| Dec 31, 2022 | -43,599.00 |
| Sep 30, 2022 | 81,629.00 |
| Jun 30, 2022 | 109,549.00 |
| Mar 31, 2022 | 33,079.00 |
| Dec 31, 2021 | 109,180.00 |
| Sep 30, 2021 | 549,053.00 |
| Jun 30, 2021 | 116,188.00 |
| Mar 31, 2021 | 129,661.00 |
Ovid Therapeutics Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=OVID&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "OVID", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=OVID&period=max&api_key=YOUR_API_KEY");
const data = await res.json();